<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7466376\results\search\drug\results.xml">
  <result pre="and acute lung injury are known. It improves oxygenation rates," exact="glutathione" post="levels and strengthens the immune response. It reduces mechanical"/>
  <result pre="should be selected avoiding subsequent collateral damage for the patient." exact="Chloroquine" post="and Hydroxychloroquine Chloroquine has been proposed for COVID-19 treatment."/>
  <result pre="selected avoiding subsequent collateral damage for the patient. Chloroquine and" exact="Hydroxychloroquine" post="Chloroquine has been proposed for COVID-19 treatment. This drug"/>
  <result pre="avoiding subsequent collateral damage for the patient. Chloroquine and Hydroxychloroquine" exact="Chloroquine" post="has been proposed for COVID-19 treatment. This drug has"/>
  <result pre="is not expensive and has a well-established clinical safety profile." exact="Chloroquine" post="and hydroxychloroquine are nowadays employed against autoimmune disease and"/>
  <result pre="expensive and has a well-established clinical safety profile. Chloroquine and" exact="hydroxychloroquine" post="are nowadays employed against autoimmune disease and in the"/>
  <result pre="of some DNA and RNA viruses, such as SARS-CoV-1 [46]." exact="Chloroquine" post="is a form of quinine consisting of an acidotropic"/>
  <result pre="viruses, such as SARS-CoV-1 [46]. Chloroquine is a form of" exact="quinine" post="consisting of an acidotropic amine. It was synthesized in"/>
  <result pre="Bayer and surged as an efficient replacement for natural quinine." exact="Quinine" post="is found in Cinchona trees that grow in Peru."/>
  <result pre="found in Cinchona trees that grow in Peru. In vitro," exact="chloroquine" post="is a versatile bioactive agent that has antiviral activity"/>
  <result pre="and the hepatitis B virus which are DNA viruses [46]." exact="Chloroquine" post="suppresses the entrance of viruses into host cells and"/>
  <result pre="into host cells and inhibits glycosylation of viral proteins [47]." exact="Chloroquine" post="was effective in decreasing viral replication, in a concentration"/>
  <result pre="it easily penetrates in tissues, such as the lung [47]." exact="Chloroquine" post="blocks viral infection by alkalinizing the endosomal pH in"/>
  <result pre="the nucleic acid and the required enzymes for replication [48]." exact="Chloroquine" post="also alters the immune system functioning through activation of"/>
  <result pre="through activation of cell signaling and pro-inflammatory cytokine control [49]." exact="Chloroquine" post="suppresses phosphorylation of caspase-1 and of the p38 mitogen-activated"/>
  <result pre="the viruses to replicate. In the model of HCoV-229 coronavirus," exact="chloroquine" post="inhibited the virus by suppression of p38 mitogen-activated protein"/>
  <result pre="the virus by suppression of p38 mitogen-activated protein kinase. Moreover," exact="chloroquine" post="reduced IL-1Î² release and diminished interleukin IL-1Î² mRNA expression"/>
  <result pre="release and diminished interleukin IL-1Î² mRNA expression in THP-1 cells." exact="Chloroquine" post="also decreased IL-6 and IL-1 in monocytes and macrophages"/>
  <result pre="Clinical studies have recommended a dose of 500 mg of" exact="chloroquine" post="twice per day for 10 days, in patients with"/>
  <result pre="no contraindications to the drug. In adults 600 mg of" exact="chloroquine" post="can be given and then 300 mg after 12"/>
  <result pre="effects, the drug has a long half-life (30 h) [52]." exact="Chloroquine" post="was efficient against SARS-CoV-2 in Vero E6 cells using"/>
  <result pre="and EC90 values) of 1.13 Î¼M and 6.90 Î¼M. Therefore," exact="chloroquine" post="improves the evolution of pneumonia in COVID-19 patients [53]."/>
  <result pre="chloroquine improves the evolution of pneumonia in COVID-19 patients [53]." exact="Chloroquine" post="also diminishes the activity of the enzyme quinone reductase"/>
  <result pre="on cell transmembrane proteins that participate in ligand recognition. When" exact="chloroquine" post="interferes with the biosynthesis of sialic acid could be"/>
  <result pre="such as the orthomyxoviruses and the human coronavirus HCoV-O43 [55]." exact="Hydroxychloroquine" post="is different from chloroquine since it has hydroxyl group"/>
  <result pre="and the human coronavirus HCoV-O43 [55]. Hydroxychloroquine is different from" exact="chloroquine" post="since it has hydroxyl group at the end of"/>
  <result pre="the side chain. This molecule can be ingested orally as" exact="hydroxychloroquine" post="sulfate. The pharmacokinetics of hydroxychloroquine resembles that of chloroquine,"/>
  <result pre="can be ingested orally as hydroxychloroquine sulfate. The pharmacokinetics of" exact="hydroxychloroquine" post="resembles that of chloroquine, having a rapid gastrointestinal absorption"/>
  <result pre="having a rapid gastrointestinal absorption and elimination by the kidney." exact="Hydroxychloroquine" post="has a good tolerance and can be used in"/>
  <result pre="[56]. In the present global infection of SARS-CoV-2, treatment with" exact="hydroxychloroquine" post="combined with azithromycin, a macrolide antibiotic, resulted in 100%"/>
  <result pre="cured in contrast with only 57.1% of subjects treated with" exact="hydroxychloroquine" post="alone and 12.5% with the control group. It was"/>
  <result pre="12.5% with the control group. It was therefore concluded that" exact="chloroquine" post="and hydroxychloroquine should be used in patients suffering from"/>
  <result pre="the control group. It was therefore concluded that chloroquine and" exact="hydroxychloroquine" post="should be used in patients suffering from pneumonia caused"/>
  <result pre="be used in patients suffering from pneumonia caused by SARS-CoV-2." exact="Chloroquine" post="has also been proposed as a preventative treatment for"/>
  <result pre="[57]. In that study the authors gave 600 mg of" exact="chloroquine" post="for 14 days and found a 50% efficacy of"/>
  <result pre="the viral load at day 7. They also reported that" exact="hydroxychloroquine" post="failed in two patients (mother and son) and concluded"/>
  <result pre="side effects of the drug administration [58]. 4. Drawbacks of" exact="Chloroquine" post="and Hydroxychloroquine Cardiovascular side effects, particularly prolongation of the"/>
  <result pre="of the drug administration [58]. 4. Drawbacks of Chloroquine and" exact="Hydroxychloroquine" post="Cardiovascular side effects, particularly prolongation of the QT interval"/>
  <result pre="clinical trials registered on the effects of the use of" exact="chloroquine" post="and hydroxychloroquine. There is a Clinical Trial in which"/>
  <result pre="currents. In autoimmune disease patients, drug-induced arrhythmias, caused by chloroquine," exact="methotrexate" post="and corticosteroids may also appear [60]. Therefore, the use"/>
  <result pre="showed that Remdesivir and INF-Î² were more effective than lopinavir," exact="ritonavir" post="and INF-Î² in-vitro and in a MERS-CoV mouse model."/>
  <result pre="In the treatment of SARS-CoV-2, antivirals which include oseltamivir, lopinavir/ritonavir," exact="ganciclovir" post="and ribavirin have been employed [65]. 5. Anti-Inflammatory Drugs"/>
  <result pre="treatment of SARS-CoV-2, antivirals which include oseltamivir, lopinavir/ritonavir, ganciclovir and" exact="ribavirin" post="have been employed [65]. 5. Anti-Inflammatory Drugs The release"/>
  <result pre="the IL-18RÎ± receptor. IL-37 acts on mTOR thus elevating the" exact="adenosine" post="monophosphate kinase that has immunosuppressive activity. By inhibiting IL-6,"/>
  <result pre="may be combined with antivirals that act directly (lopinavir or" exact="ritonavir" post="and Remdesivir) and which are now being tested in"/>
  <result pre="in the liver and most of the metabolites produced from" exact="chloroquine" post="and hydroxychloroquine sulfate, oseltamivir, ribavirin and lopinavir/ritonavir, are eliminated"/>
  <result pre="liver and most of the metabolites produced from chloroquine and" exact="hydroxychloroquine" post="sulfate, oseltamivir, ribavirin and lopinavir/ritonavir, are eliminated in urine."/>
  <result pre="of the metabolites produced from chloroquine and hydroxychloroquine sulfate, oseltamivir," exact="ribavirin" post="and lopinavir/ritonavir, are eliminated in urine. Therefore, their metabolism"/>
  <result pre="treat non-cirrhotic genotype 1b chronic hepatitis C, combined with ribavirin," exact="ritonavir" post="and peginterferon-Î± [75]. Currently, a trial study has been"/>
  <result pre="which, when combined with ritonavir, predisposes to severe hypotension [78]." exact="Ritonavir" post="increases the concentration of alfuzosine and may constitute a"/>
  <result pre="are also being treated for arrhythmias [79]. The use of" exact="amiodarone" post="increases its plasmatic concentrations and increases the risk of"/>
  <result pre="is also common in elderly patients. Their use together with" exact="ritonavir" post="and pimozide increases the risk of severe hematologic diseases."/>
  <result pre="common in elderly patients. Their use together with ritonavir and" exact="pimozide" post="increases the risk of severe hematologic diseases. The use"/>
  <result pre="increases the risk of severe hematologic diseases. The use of" exact="ritonavir" post="with antihistaminic drugs such as astemizol, terfenadine or with"/>
  <result pre="The use of ritonavir with antihistaminic drugs such as astemizol," exact="terfenadine" post="or with drugs that control the gastric motility increases"/>
  <result pre="to arrhythmias [77]. Furthermore, the use of sedatives such as" exact="sildenafil" post="which is also used to control pulmonary arterial hypertension"/>
  <result pre="combined with ritonavir. Moreover, the concentration and clinical effects of" exact="lopinavir" post="and ritonavir may be decreased in patients that use"/>
  <result pre="ritonavir. Moreover, the concentration and clinical effects of lopinavir and" exact="ritonavir" post="may be decreased in patients that use alternative medicine"/>
  <result pre="the following antioxidant compounds for the treatment of COVID-19. 11." exact="N-acetylcysteine" post="Preclinical studies have proposed the administration of N-acetylcysteine (NAC),"/>
  <result pre="COVID-19. 11. N-acetylcysteine Preclinical studies have proposed the administration of" exact="N-acetylcysteine" post="(NAC), a precursor of glutathione, as a strategy to"/>
  <result pre="stress lung injury since it increases the content of intracellular" exact="glutathione" post="[89]. A central feature of many lung diseases is"/>
  <result pre="many lung diseases is the alterations of the metabolism of" exact="glutathione" post="that occurs both in the alveoli and lung tissue"/>
  <result pre="alveoli and lung tissue [90]. NAC increases the synthesis of" exact="glutathione" post="synthesis, elevates glutathione-S-transferase activity and has a direct action"/>
  <result pre="tissue myeloperoxidase activity or 3-nitrotyrosine levels [91]. The application of" exact="N-acetylcysteine" post="decreases the levels of IL-8, IL-6, ICAM and the"/>
  <result pre="absorbed at the intestinal level through the sodium-dependent transporter of" exact="vitamin C," post="filtered freely in the glomerulus and reabsorbed at the"/>
  <result pre="of leukocytes in the microcirculation [104]. Decreased plasma levels of" exact="vitamin C" post="may be due to inadequate intake, acute or chronic"/>
  <result pre="increased oxidative stress or increased loss [105]. Low levels of" exact="vitamin C" post="have been documented in critically ill patients in several"/>
  <result pre="and mortality [107]. In a study where the safety of" exact="vitamin C" post="administration in patients with severe sepsis was evaluated and"/>
  <result pre="with severe sepsis was evaluated and two different doses of" exact="vitamin C" post="were compared (50 mg/kg/24 h and 200 mg/kg/24 h)"/>
  <result pre="No adverse effects were reported in the patients who received" exact="vitamin C" post="infusion. The patients who received vitamin C had a"/>
  <result pre="patients who received vitamin C infusion. The patients who received" exact="vitamin C" post="had a greater decrease in the SOFA score compared"/>
  <result pre="group. Decreased C-reactive protein and procalcitonin were reported in the" exact="vitamin C" post="group. Lower levels of thrombomodulin were found in the"/>
  <result pre="C group. Lower levels of thrombomodulin were found in the" exact="vitamin C" post="group compared to placebo. 28-day mortality was also lower"/>
  <result pre="to placebo. 28-day mortality was also lower in the low-dose" exact="vitamin C" post="group (38.1%) compared to the high-dose group (50.6%) and"/>
  <result pre="days or days of ICU stay. A 96-h infusion of" exact="vitamin C" post="in contrast to placebo did not improve vascular injury,"/>
  <result pre="further research was necessary to evaluate the potential role of" exact="vitamin C" post="for other outcomes in ARDS [108]. However, diets enriched"/>
  <result pre="diets enriched with antioxidants (320 IU/L vitamin E, 840 mg/L" exact="vitamin C" post="and 320 mg/L taurine), eicosapentaenoic acid (4.5 g/L) and"/>
  <result pre="vitamin E, 840 mg/L vitamin C and 320 mg/L taurine)," exact="eicosapentaenoic acid" post="(4.5 g/L) and gamma-linolenic acid (4.3 g/L) showed a"/>
  <result pre="patients receiving 60 IU/L Î±-tocopherol (vitamin E) and 340 mg/L" exact="vitamin C" post="through an oro-gastric tube. There was a lower multiple"/>
  <result pre="There was a lower multiple organ failure. Vitamin E and" exact="vitamin C" post="administration also decreased the length of ICU stay. However,"/>
  <result pre="and fewer days of mechanical ventilation in patients treated with" exact="vitamin C" post="and vitamin E. Another randomized, double-blind, placebo-controlled study found"/>
  <result pre="days of mechanical ventilation in patients who were treated with" exact="vitamin C" post="and vitamin E [113]. The combined effect of therapy"/>
  <result pre="[113]. The combined effect of therapy with vitamin E and" exact="vitamin C" post="in severe post-operative patients resulted in a decrease in"/>
  <result pre="which results from COVID-19 [115]. 13. Melatonin N-acetyl-5-methoxytryptamine also called" exact="melatonin" post="(MT) is the main endogenous product of secretion of"/>
  <result pre="[119] and reduce levels of hydroperoxide in mitochondria by restoring" exact="glutathione" post="homeostasis and mitochondrial function in organelles under oxidative stress"/>
  <result pre="stimulate gamma-glutamyl cysteine synthase; therefore, it can increase the intracellular" exact="glutathione" post="synthesis [121]. Another of its antioxidant mechanisms is through"/>
  <result pre="the use of diclofenac, celecoxib, fluvastatin, glipizide, ibuprofen, irbesartan, losartan" exact="phenytoin" post="and others with cytochrome p450 2C9 substrate (CYP2C9) and"/>
  <result pre="(CYP2C9) and with p450 2C (CYP2C8) such as paclitaxel, rosiglitazone," exact="amiodarone" post="and verapamil. However, QRC is currently a promise as"/>
  <result pre="be considered is potentially effective as an antiviral [131]. 15." exact="Pentoxifylline" post="Pentoxifylline is a xanthine indicated in some severe cases"/>
  <result pre="considered is potentially effective as an antiviral [131]. 15. Pentoxifylline" exact="Pentoxifylline" post="is a xanthine indicated in some severe cases of"/>
  <result pre="blood cells rendering it more malleable, thus improving blood perfusion." exact="Pentoxifylline" post="exerts several antioxidant and anti-inflammatory activities; it restores glutathione"/>
  <result pre="perfusion. Pentoxifylline exerts several antioxidant and anti-inflammatory activities; it restores" exact="glutathione" post="levels, it maintains mitochondrial viability, it inhibits TNF-Î± production,"/>
  <result pre="with a mean gestational age of 30 weeks, administration of" exact="pentoxifylline" post="(5 mg/kg/h iv for 6 h for 6 days)"/>
  <result pre="no difference in short-term morbidity was observed between treated with" exact="pentoxifylline" post="and untreated neonates with sepsis [135]. In a meta-analysis"/>
  <result pre="sepsis [135]. In a meta-analysis involving 6 studies, with the" exact="pentoxifylline" post="administration of in septic infants, pentoxifylline was shown to"/>
  <result pre="6 studies, with the pentoxifylline administration of in septic infants," exact="pentoxifylline" post="was shown to be effective in decreasing length of"/>
  <result pre="in a subgroup analysis that resulted in the conclusion that" exact="pentoxifylline" post="may be a beneficial adjuvant treatment in sepsis [136]"/>
  <result pre="[136] and could also be used in COVID-19. Treatment with" exact="pentoxifylline" post="is contraindicated in patients with recent cerebral or retinal"/>
  <result pre="supplementation has been reported to cause better oxygenation rates, increased" exact="glutathione" post="and a stronger immune response. There is a reduction"/>
  <result pre="in ALI/ARDS, have been reported. It improves oxygenation rates; increases" exact="glutathione" post="and promotes a stronger immune response. There is a"/>
  <result pre="of a window of opportunityCMAJ20051731054106510.1503/cmaj.05063216247103 42.ClappB.R.HingoraniA.D.KharbandaR.K.Mohamed-AliV.StephensJ.W.VallanceP.MacAllisterR.J.Inflammation-induced endothelial dysfunction involves reduced" exact="nitric oxide" post="bioavailability and increased oxidant stressCardiovasc. Res.20046417217810.1016/j.cardiores.2004.06.02015364625 43.PÃ©rez-TorresI.Manzano-PechL.Rubio-RuÃ­zM.E.SotoM.E.Guarner-LansV.Nitrosative stress and"/>
  <result pre="mitochondrial dysfunction in sepsis-induced organ failureCrit. Care20061022823210.1186/cc501416953900 46.DanL.XiaodanL.YonggangZ.JoeyK.LingL.YiyiZ.XuC.LiQ.SunX.TianH.et al.Chloroquine and" exact="hydroxychloroquine" post="are associated with reduced cardiovascular risk: A systematic review"/>
  <result pre="the 2019 novel coronavirus SARS-CoV-2Int. J. Antimicrob. Agents20205510592310.1016/j.ijantimicag.2020.10592332070753 48.TouretF.de LamballerieX.Of" exact="chloroquine" post="and COVID-19Antivir. Res.202017710476210.1016/j.antiviral.2020.10476232147496 49.Al-BariM.A.A.Targeting endosomal acidification by chloroquine analogs"/>
  <result pre="48.TouretF.de LamballerieX.Of chloroquine and COVID-19Antivir. Res.202017710476210.1016/j.antiviral.2020.10476232147496 49.Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
  <result pre="the treatment of emerging viral diseasesPharmacol. Res. Perspec.201750029310.1002/prp2.293 50.RoutyJ.P.AngelJ.B.PatelM.KanagarathamC.RadziochD.KemaI.GilmoreN.AncutaP.SingerJ.JenabianM.A.Assessment of" exact="chloroquine" post="as a modulator of immune activation to improve CD4"/>
  <result pre="receiving antiretroviral therapyHIV Med.201516485610.1111/hiv.1217124889179 51.Van den BorneB.E.DijkmansB.A.de RooijH.H.le CessieS.VerweijC.L.Chloroquine and" exact="hydroxychloroquine" post="equally affect tumor necrosis factor-alpha, interleukin 6 and interferon-gamma"/>
  <result pre="mononuclear cellsJ. Rheumatol.19972455609002011 52.DevauxC.A.RolainJ.ColsonP.RaoultD.New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: What to expect for COVID-19Int. J. Antimicrob."/>
  <result pre="Agents202010593810.1016/j.ijantimicag.2020.10593832171740 53.CortegianiA.IngogliaG.IppolitoM.GiarratanoA.EinavS.A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19J. Crit. Care20205727928310.1016/j.jcrc.2020.03.00532173110 54.ColsonP.RolainJ.M.LagierJ.C.BrouquiP.RaoultD.Chloroquine and"/>
  <result pre="chloroquine for the treatment of COVID-19J. Crit. Care20205727928310.1016/j.jcrc.2020.03.00532173110 54.ColsonP.RolainJ.M.LagierJ.C.BrouquiP.RaoultD.Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19Int. J. Antimicrob. Agents20205510593210.1016/j.ijantimicag.2020.10593232145363"/>
  <result pre="infectionsAdv. Carbohydr. Chem. Biochem.2019766511130851744 57.SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against coronavirus disease 2019 (COVID-19):" exact="Chloroquine" post="or hydroxychloroquineInt. J. Antimicrob. Agents20205510594510.1016/j.ijantimicag.2020.10594532194152 58.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.Hydroxychloroquine and azithromycin as"/>
  <result pre="2019 (COVID-19): Chloroquine or hydroxychloroquineInt. J. Antimicrob. Agents20205510594510.1016/j.ijantimicag.2020.10594532194152 58.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: Results of an open-label"/>
  <result pre="effect of oxime derivatives in isolated rat aorta: Role of" exact="nitric oxide" post="(NO) formation in smooth muscleBiochem. Pharmacol.2004671203121410.1016/j.bcp.2003.11.01215006555 85.SingerM.DeutschmanC.S.SeymourC.W.Shankar-HariM.DjillaliB.M.BauerM.BellomoR.BernardG.R.ChicheJ.D.CoopersmithC.M.et al.The third"/>
  <result pre="elastase in acute lung injuryEur. J. Pharmacol.200245111010.1016/S0014-2999(02)02182-912223222 91.RahmanI.MacNeeW.Regulation of redox" exact="glutathione" post="levels and gene transcription in lung inflammation: Therapeutic approachesFree"/>
  <result pre="oleic acid-induced lung injuryPulm. Pharmacol. Ther.20041726327010.1016/j.pupt.2004.05.00215477121 93.SciutoA.M.StricklandP.T.KennedyT.P.GurtnerG.H.Protective effects of N" exact="acetylcysteine" post="treatment after phosgene exposure in rabbitsAm. J. Respir. Crit."/>
  <result pre="cardiac performance in patients with septic shockCrit. Care Med.1996241302131010.1097/00003246-199608000-000068706483 98.SpapenH.ZhangH.DemanetC.VleminckxW.VincentJ.L.HuyghensL.Does" exact="N-acetyl-L-cysteine" post="influence cytokine response during early human septic shockChest19981131616162410.1378/chest.113.6.16169631802 99.MolnÃ¡rZ.ShearerE.LoweD.N-Acetylcysteine"/>
  <result pre="a prospective, randomized, double-blind studyCrit. Care Med.200023799380710.1097/00003246-200012000-00006 101.PatersonR.L.GalleyH.F.WebsterN.R.The effect of" exact="N-acetylcysteine" post="on nuclear factor-kappa B activation, interleukin-6, interleukin-8 and intercellular"/>
  <result pre="in patients with sepsisCrit. Care Med.2003312574257810.1097/01.CCM.0000089945.69588.1814605526 102.BernardG.R.WheelerA.P.AronsM.M.MorrisP.E.PazH.L.RussellJ.A.WrightP.E.A trial of antioxidants" exact="N-acetylcysteine" post="and procysteine in ARDS. The Antioxidant in ARDS Study"/>
  <result pre="in ARDS Study GroupChest199711216417210.1378/chest.112.1.1649228372 103.BergerM.M.VitaminC.requirements in parenteral nutritionGastroenterology2009137707810.1053/j.gastro.2009.08.012 104.MayJ.M.HarrisonF.E.Role of" exact="vitamin C" post="in the function of the vascular endotheliumAntioxid. Redox Signal.2013192068208310.1089/ars.2013.520523581713"/>
  <result pre="Metab. Care20151819320110.1097/MCO.000000000000014825635594 106.Oudemans-van StraatenH.M.Spoelstra-de ManA.M.de WaardM.C.Vitamin C revisitedCrit. Care20141846010.1186/s13054-014-0460-x25185110 107.SchorahC.J.DowningC.PiripitsiA.GallivanL.Al-HazaaA.H.SandersonM.J.BodenhamA.Total" exact="vitamin C," post="ascorbic acid and dehydroascorbic acid concentrations in plasma of"/>
  <result pre="patientsAm. J. Clin. Nutr.19966376076510.1093/ajcn/63.5.7608615361 108.Spoelstra-de ManA.M.E.de GroothH.J.ElbersP.W.G.Oudemans-van StraatenH.M.Response to Adjuvant" exact="vitamin C" post="in cardiac arrest patients undergoing renal replacement therapy: An"/>
  <result pre="An appeal for a higher high-doseCrit. Care20182235010.1186/s13054-018-2200-030567557 109.FowlerA.A.TruwitJ.D.HiteR.D.MorrisP.E.DeWildeC.PridayA.FisherB.ThackerL.R.NatarajanR.BrophyD.F.et al.Effect of" exact="vitamin C" post="infusion on organ failure and biomarkers of inflammation and"/>
  <result pre="The CITRIS-ALI randomized clinical trialJAMA20193221261127031573637 110.Pontes-ArrudaA.AragÃ£oA.M.AlbuquerqueJ.D.Effects of enteral feeding with" exact="eicosapentaenoic acid," post="gammalinolenic acid and antioxidants in mechanically ventilated patients with"/>
  <result pre="randomized controlled trialPediatr. Infect. Dis. J.20153414314810.1097/INF.0000000000000698 135.AkdagA.DilmenU.HaqueK.DilliD.ErdeveO.GoekmenT.Role of IgM-enriched intravenous" exact="pentoxifylline" post="and/or immunoglobulin in the treatment of neonatal sepsisAm. J."/>
  <result pre="renin-angiotensin-aldosterone system, ATR1 = receptor type 1 losartan. ALT =" exact="alanine" post="aminotransferase, AST = aspartate aminotransferase. Figure 4 Ultrastructural features"/>
  <result pre="addressed in this review. Treatment Mechanism of Action Adverse Effect" exact="Chloroquine" post="and Hydroxychloroquine â†&quot; IL-1Î² mRNA expression in THP-1 cells."/>
  <result pre="this review. Treatment Mechanism of Action Adverse Effect Chloroquine and" exact="Hydroxychloroquine" post="â†&quot; IL-1Î² mRNA expression in THP-1 cells. Cardiovascular effects,"/>
  <result pre="Treatment Antioxidant Effect Clinical Effect NAC â†‘ The synthesis of" exact="glutathione" post="and glutathione-S-transferase activity [100]. Lipid peroxidation, chloramine concentration, damage"/>
  <result pre="[108,109]. The combined effect of therapy with vitamin E and" exact="vitamin C" post="in severe post-operative patients resulted in a decrease in"/>
  <result pre="protein phosphatase 2A and TNF-Î± [109,110,111,112]. MT â†‘ The intracellular" exact="glutathione" post="synthesis [122]. Melatonin enhances the immune response by improving"/>
  <result pre="protection. â†&quot; The levels of hydroperoxide in mitochondria by restoring" exact="glutathione" post="homeostasis and mitochondrial function in organelles under oxidative stress"/>
  <result pre="[126,127,128]. It has antiviral, cardioprotective, antioxidant, anti-inflammatory and anti-carcinogenic effects." exact="Pentoxifylline" post="â†‘ The glutathione levels, it maintains mitochondrial viability [133]."/>
  <result pre="antiviral, cardioprotective, antioxidant, anti-inflammatory and anti-carcinogenic effects. Pentoxifylline â†‘ The" exact="glutathione" post="levels, it maintains mitochondrial viability [133]. Decreases duration of"/>
  <result pre="total cholesterol, HDL, LDL, triglycerides, D dimer, troponins, natriuretic peptide," exact="creatine" post="phosphokinase, Cl, Na, K, magnesium, phosphorus. Evaluation of hepatic"/>
  <result pre="the pulmonary function is compromised, a combination of NAC and" exact="vitamin C" post="is suggested. (This applies to all cases). NAC dose:"/>
  <result pre="used together with some antihypertensive drugs. Sedatives, Luvox contraceptives and" exact="cocaine" post="increase the effect of MT. Verapamil, nifedipine, caffeine, alcohol"/>
  <result pre="and cocaine increase the effect of MT. Verapamil, nifedipine, caffeine," exact="alcohol" post="and immunosuppressors decrease the MT effect. Vit C dose:"/>
  <result pre="mellitus, hypertension, or Parkinsonâ€™s disease. Aluminum, estrogens, protease inhibitors, antivirals:" exact="nelfinavir" post="amprenavir, ritonavir, saquinavir, statins, glimepiride, glipizide, metformin, pioglitazone, rosiglitazone,"/>
  <result pre="It should not be used when retinitis pigmentosa is present." exact="Simvastatin" post="and niacin, chemotherapy, anticoagulants and antiplatelet agents and non-steroidal"/>
  <result pre="Measures that are jointly evaluated according to the initial evaluation." exact="Pentoxifylline" post="(vasodilator, inhibitor of IL-6), at a dose of 400"/>
  <result pre="not tolerate it. (The doses of the elected antioxidants and/or" exact="pentoxifylline" post="are similar in all cases. The selection must be"/>
  <result pre="E + pentoxifylline.Monitor if the patient uses antiplatelet or anticoagulant" exact="digoxin" post="or has an arrhythmia. Ischemic Heart DiseaseNAC or MT"/>
  <result pre="choice except contraindication ArrhythmiasNAC or MT or QRC or +" exact="Pentoxifylline" post="Chronic Obstructive Pulmonary DiseaseNAC or MT or QRC or"/>
  <result pre="+ PentoxifyllineSmokingNAC or MT or QRC or Vit C +" exact="Pentoxifylline" post="ImmuneSuppressionNAC or Vit E (if anticoagulants are not being"/>
  <result pre="N-acetylcysteine, MT = melatonin, QRC = quercetin, vit C =" exact="vitamin C," post="vit E = vitamin E, SAH = systemic arterial"/>
 </snippets>
</snippetsTree>
